- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x RET: RETINAL(Covalent)
- 57 x LFA: EICOSANE(Non-covalent)(Non-functional Binders)
LFA.2: 3 residues within 4Å:- Chain A: W.78
- Ligands: LFA.3, LFA.15
Ligand excluded by PLIPLFA.3: 9 residues within 4Å:- Chain A: V.53, N.54, W.78, T.82
- Chain C: V.122, L.125
- Ligands: LFA.2, LFA.14, LFA.15
Ligand excluded by PLIPLFA.4: 2 residues within 4Å:- Chain A: L.200
- Ligands: LFA.13
Ligand excluded by PLIPLFA.5: 2 residues within 4Å:- Chain A: L.202
- Ligands: LFA.17
Ligand excluded by PLIPLFA.6: 2 residues within 4Å:- Chain A: L.20, Y.24
Ligand excluded by PLIPLFA.7: 4 residues within 4Å:- Chain A: L.85, P.89, L.90
- Ligands: LFA.20
Ligand excluded by PLIPLFA.8: 4 residues within 4Å:- Chain A: W.12
- Chain C: V.131, L.132
- Ligands: LFA.9
Ligand excluded by PLIPLFA.9: 3 residues within 4Å:- Chain A: W.12
- Ligands: LFA.8, LFA.10
Ligand excluded by PLIPLFA.10: 4 residues within 4Å:- Chain A: I.9, W.12, L.13
- Ligands: LFA.9
Ligand excluded by PLIPLFA.11: 4 residues within 4Å:- Chain A: L.132, S.133, A.136
- Ligands: LFA.12
Ligand excluded by PLIPLFA.12: 2 residues within 4Å:- Ligands: LFA.11, LFA.13
Ligand excluded by PLIPLFA.13: 5 residues within 4Å:- Chain A: L.139, W.142, L.194
- Ligands: LFA.4, LFA.12
Ligand excluded by PLIPLFA.14: 5 residues within 4Å:- Chain A: N.54, F.86
- Chain C: V.114, L.115
- Ligands: LFA.3
Ligand excluded by PLIPLFA.15: 4 residues within 4Å:- Ligands: LFA.2, LFA.3, LFA.37, LFA.59
Ligand excluded by PLIPLFA.16: 3 residues within 4Å:- Chain A: L.90, Y.93
- Chain C: Y.107
Ligand excluded by PLIPLFA.17: 2 residues within 4Å:- Chain A: W.192
- Ligands: LFA.5
Ligand excluded by PLIPLFA.20: 6 residues within 4Å:- Chain A: Y.93, A.101, R.103, I.106, Y.107
- Ligands: LFA.7
Ligand excluded by PLIPLFA.21: 2 residues within 4Å:- Chain A: L.20, Y.24
Ligand excluded by PLIPLFA.22: 8 residues within 4Å:- Chain A: M.22, I.45, A.49
- Chain C: L.112, L.115, A.147, F.148, F.155
Ligand excluded by PLIPLFA.24: 3 residues within 4Å:- Chain B: W.78
- Ligands: LFA.25, LFA.37
Ligand excluded by PLIPLFA.25: 9 residues within 4Å:- Chain A: V.122, L.125
- Chain B: V.53, N.54, W.78, T.82
- Ligands: LFA.24, LFA.36, LFA.37
Ligand excluded by PLIPLFA.26: 2 residues within 4Å:- Chain B: L.200
- Ligands: LFA.35
Ligand excluded by PLIPLFA.27: 2 residues within 4Å:- Chain B: L.202
- Ligands: LFA.39
Ligand excluded by PLIPLFA.28: 2 residues within 4Å:- Chain B: L.20, Y.24
Ligand excluded by PLIPLFA.29: 4 residues within 4Å:- Chain B: L.85, P.89, L.90
- Ligands: LFA.42
Ligand excluded by PLIPLFA.30: 4 residues within 4Å:- Chain A: V.131, L.132
- Chain B: W.12
- Ligands: LFA.31
Ligand excluded by PLIPLFA.31: 3 residues within 4Å:- Chain B: W.12
- Ligands: LFA.30, LFA.32
Ligand excluded by PLIPLFA.32: 4 residues within 4Å:- Chain B: I.9, W.12, L.13
- Ligands: LFA.31
Ligand excluded by PLIPLFA.33: 4 residues within 4Å:- Chain B: L.132, S.133, A.136
- Ligands: LFA.34
Ligand excluded by PLIPLFA.34: 2 residues within 4Å:- Ligands: LFA.33, LFA.35
Ligand excluded by PLIPLFA.35: 5 residues within 4Å:- Chain B: L.139, W.142, L.194
- Ligands: LFA.26, LFA.34
Ligand excluded by PLIPLFA.36: 5 residues within 4Å:- Chain A: V.114, L.115
- Chain B: N.54, F.86
- Ligands: LFA.25
Ligand excluded by PLIPLFA.37: 4 residues within 4Å:- Ligands: LFA.15, LFA.24, LFA.25, LFA.59
Ligand excluded by PLIPLFA.38: 3 residues within 4Å:- Chain A: Y.107
- Chain B: L.90, Y.93
Ligand excluded by PLIPLFA.39: 2 residues within 4Å:- Chain B: W.192
- Ligands: LFA.27
Ligand excluded by PLIPLFA.42: 6 residues within 4Å:- Chain B: Y.93, A.101, R.103, I.106, Y.107
- Ligands: LFA.29
Ligand excluded by PLIPLFA.43: 2 residues within 4Å:- Chain B: L.20, Y.24
Ligand excluded by PLIPLFA.44: 8 residues within 4Å:- Chain A: L.112, L.115, A.147, F.148, F.155
- Chain B: M.22, I.45, A.49
Ligand excluded by PLIPLFA.46: 3 residues within 4Å:- Chain C: W.78
- Ligands: LFA.47, LFA.59
Ligand excluded by PLIPLFA.47: 9 residues within 4Å:- Chain B: V.122, L.125
- Chain C: V.53, N.54, W.78, T.82
- Ligands: LFA.46, LFA.58, LFA.59
Ligand excluded by PLIPLFA.48: 2 residues within 4Å:- Chain C: L.200
- Ligands: LFA.57
Ligand excluded by PLIPLFA.49: 2 residues within 4Å:- Chain C: L.202
- Ligands: LFA.61
Ligand excluded by PLIPLFA.50: 2 residues within 4Å:- Chain C: L.20, Y.24
Ligand excluded by PLIPLFA.51: 4 residues within 4Å:- Chain C: L.85, P.89, L.90
- Ligands: LFA.64
Ligand excluded by PLIPLFA.52: 4 residues within 4Å:- Chain B: V.131, L.132
- Chain C: W.12
- Ligands: LFA.53
Ligand excluded by PLIPLFA.53: 3 residues within 4Å:- Chain C: W.12
- Ligands: LFA.52, LFA.54
Ligand excluded by PLIPLFA.54: 4 residues within 4Å:- Chain C: I.9, W.12, L.13
- Ligands: LFA.53
Ligand excluded by PLIPLFA.55: 4 residues within 4Å:- Chain C: L.132, S.133, A.136
- Ligands: LFA.56
Ligand excluded by PLIPLFA.56: 2 residues within 4Å:- Ligands: LFA.55, LFA.57
Ligand excluded by PLIPLFA.57: 5 residues within 4Å:- Chain C: L.139, W.142, L.194
- Ligands: LFA.48, LFA.56
Ligand excluded by PLIPLFA.58: 5 residues within 4Å:- Chain B: V.114, L.115
- Chain C: N.54, F.86
- Ligands: LFA.47
Ligand excluded by PLIPLFA.59: 4 residues within 4Å:- Ligands: LFA.15, LFA.37, LFA.46, LFA.47
Ligand excluded by PLIPLFA.60: 3 residues within 4Å:- Chain B: Y.107
- Chain C: L.90, Y.93
Ligand excluded by PLIPLFA.61: 2 residues within 4Å:- Chain C: W.192
- Ligands: LFA.49
Ligand excluded by PLIPLFA.64: 6 residues within 4Å:- Chain C: Y.93, A.101, R.103, I.106, Y.107
- Ligands: LFA.51
Ligand excluded by PLIPLFA.65: 2 residues within 4Å:- Chain C: L.20, Y.24
Ligand excluded by PLIPLFA.66: 8 residues within 4Å:- Chain B: L.112, L.115, A.147, F.148, F.155
- Chain C: M.22, I.45, A.49
Ligand excluded by PLIP- 6 x SO4: SULFATE ION(Non-functional Binders)
SO4.18: 2 residues within 4Å:- Chain A: R.172, K.176
2 PLIP interactions:2 interactions with chain A- Salt bridges: A:R.172, A:K.176
SO4.19: 2 residues within 4Å:- Chain A: K.176, R.179
2 PLIP interactions:2 interactions with chain A- Salt bridges: A:K.176, A:R.179
SO4.40: 2 residues within 4Å:- Chain B: R.172, K.176
2 PLIP interactions:2 interactions with chain B- Salt bridges: B:R.172, B:K.176
SO4.41: 2 residues within 4Å:- Chain B: K.176, R.179
2 PLIP interactions:2 interactions with chain B- Salt bridges: B:K.176, B:R.179
SO4.62: 2 residues within 4Å:- Chain C: R.172, K.176
2 PLIP interactions:2 interactions with chain C- Salt bridges: C:R.172, C:K.176
SO4.63: 2 residues within 4Å:- Chain C: K.176, R.179
2 PLIP interactions:2 interactions with chain C- Salt bridges: C:K.176, C:R.179
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Shevchenko, V. et al., Crystal Structure of Escherichia coli-Expressed Haloarcula marismortui Bacteriorhodopsin I in the Trimeric Form. Plos One (2014)
- Release Date
- 2014-12-17
- Peptides
- Bacteriorhodopsin: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x RET: RETINAL(Covalent)
- 57 x LFA: EICOSANE(Non-covalent)(Non-functional Binders)
- 6 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Shevchenko, V. et al., Crystal Structure of Escherichia coli-Expressed Haloarcula marismortui Bacteriorhodopsin I in the Trimeric Form. Plos One (2014)
- Release Date
- 2014-12-17
- Peptides
- Bacteriorhodopsin: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A - Membrane
-
We predict this structure to be a membrane protein.